177 related articles for article (PubMed ID: 24631664)
1. Strong dimerization of wild-type ErbB2/Neu transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma membranes.
Placone J; He L; Del Piccolo N; Hristova K
Biochim Biophys Acta; 2014 Sep; 1838(9):2326-30. PubMed ID: 24631664
[TBL] [Abstract][Full Text] [Related]
2. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
3. High-throughput selection of transmembrane sequences that enhance receptor tyrosine kinase activation.
He L; Hoffmann AR; Serrano C; Hristova K; Wimley WC
J Mol Biol; 2011 Sep; 412(1):43-54. PubMed ID: 21767549
[TBL] [Abstract][Full Text] [Related]
4. Proline localized to the interaction interface can mediate self-association of transmembrane domains.
Sal-Man N; Gerber D; Shai Y
Biochim Biophys Acta; 2014 Sep; 1838(9):2313-8. PubMed ID: 24841754
[TBL] [Abstract][Full Text] [Related]
5. Measuring the energetics of membrane protein dimerization in mammalian membranes.
Chen L; Novicky L; Merzlyakov M; Hristov T; Hristova K
J Am Chem Soc; 2010 Mar; 132(10):3628-35. PubMed ID: 20158179
[TBL] [Abstract][Full Text] [Related]
6. Effects of the oncogenic V(664)E mutation on membrane insertion, structure, and sequence-dependent interactions of the Neu transmembrane domain in micelles and model membranes: an integrated biophysical and simulation study.
Beevers AJ; Nash A; Salazar-Cancino M; Scott DJ; Notman R; Dixon AM
Biochemistry; 2012 Mar; 51(12):2558-68. PubMed ID: 22385253
[TBL] [Abstract][Full Text] [Related]
7. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
Sajot N; Genest M
J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain.
He L; Shobnam N; Hristova K
Biochim Biophys Acta; 2011 Jan; 1808(1):253-9. PubMed ID: 20713021
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides.
Matsushita C; Tamagaki H; Miyazawa Y; Aimoto S; Smith SO; Sato T
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1646-51. PubMed ID: 23319611
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic activation of receptor tyrosine kinases in mammalian membranes.
He L; Hristova K
J Mol Biol; 2008 Dec; 384(5):1130-42. PubMed ID: 18976668
[TBL] [Abstract][Full Text] [Related]
11. Dimerization of Neu/Erb2 transmembrane domain is controlled by membrane curvature.
Khemtémourian L; Buchoux S; Aussenac F; Dufourc EJ
Eur Biophys J; 2007 Feb; 36(2):107-12. PubMed ID: 17115152
[TBL] [Abstract][Full Text] [Related]
12. The effect of hydrophilic substitutions and anionic lipids upon the transverse positioning of the transmembrane helix of the ErbB2 (neu) protein incorporated into model membrane vesicles.
Shahidullah K; Krishnakumar SS; London E
J Mol Biol; 2010 Feb; 396(1):209-20. PubMed ID: 19931543
[TBL] [Abstract][Full Text] [Related]
13. Sequence-dependent oligomerization of the Neu transmembrane domain suggests inhibition of "conformational switching" by an oncogenic mutant.
Beevers AJ; Damianoglou A; Oates J; Rodger A; Dixon AM
Biochemistry; 2010 Apr; 49(13):2811-20. PubMed ID: 20180588
[TBL] [Abstract][Full Text] [Related]
14. Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
Merzlyakov M; Chen L; Hristova K
J Membr Biol; 2007 Feb; 215(2-3):93-103. PubMed ID: 17565424
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane helix packing of ErbB/Neu receptor in membrane environment: a molecular dynamics study.
Aller P; Garnier N; Genest M
J Biomol Struct Dyn; 2006 Dec; 24(3):209-28. PubMed ID: 17054379
[TBL] [Abstract][Full Text] [Related]
16. The FRET signatures of noninteracting proteins in membranes: simulations and experiments.
King C; Sarabipour S; Byrne P; Leahy DJ; Hristova K
Biophys J; 2014 Mar; 106(6):1309-17. PubMed ID: 24655506
[TBL] [Abstract][Full Text] [Related]
17. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
Mendrola JM; Berger MB; King MC; Lemmon MA
J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
[TBL] [Abstract][Full Text] [Related]
18. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
Li E; You M; Hristova K
Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
[TBL] [Abstract][Full Text] [Related]
19. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.
Burke CL; Stern DF
Mol Cell Biol; 1998 Sep; 18(9):5371-9. PubMed ID: 9710621
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Transmembrane Domain Interactions in Neu Receptor Tyrosine Kinase by Membrane Fluidity and Cholesterol.
Hasan M; Patel D; Ellis N; Brown SP; Lewandowski JR; Dixon AM
J Membr Biol; 2019 Oct; 252(4-5):357-369. PubMed ID: 31222471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
